Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 501-550 of 6028 result(s).
CYDY CytoDyn Inc
09/24/2024 3:19:57 PM
Maybe if Leron by itself outperform (10)
CYDY CytoDyn Inc
09/23/2024 5:04:29 PM
Blueheel1 (Hulk767 on this board) h (19)
CYDY CytoDyn Inc
09/23/2024 2:46:08 PM
Did you know that if we had great n (4)
CYDY CytoDyn Inc
09/23/2024 2:17:18 PM
Apparently Medicenna is trying to d (10)
CYDY CytoDyn Inc
09/22/2024 5:50:21 AM
That study was from 2022. Avenge Bi (20)
CYDY CytoDyn Inc
09/19/2024 3:21:37 PM
OCREVUS increases your risk of... A (6)
CYDY CytoDyn Inc
09/18/2024 10:44:13 AM
Data from the first interim analysi (21)
CYDY CytoDyn Inc
09/15/2024 2:25:31 PM
the benefit-risk balance of the med (17)
CYDY CytoDyn Inc
09/15/2024 2:14:45 PM
Speaking of fuckery...that being ta (6)
CYDY CytoDyn Inc
09/15/2024 2:08:37 PM
Aramchol has been shown to down-reg (15)
CYDY CytoDyn Inc
09/11/2024 10:29:16 PM
Very odd outcomes in that trial. Th (14)
CYDY CytoDyn Inc
09/11/2024 3:02:17 PM
Drugs targeting CCR5 in asymptomati (15)
CYDY CytoDyn Inc
09/10/2024 3:39:41 PM
You know someone with Pr CA who who (7)
CYDY CytoDyn Inc
09/10/2024 3:35:50 PM
But from what we have heard, like H (23)
CYDY CytoDyn Inc
09/10/2024 3:23:00 PM
There is success in shrinking tumor (14)
CYDY CytoDyn Inc
09/10/2024 3:13:11 PM
Given the fact that Dr. Chan has re (20)
CYDY CytoDyn Inc
09/10/2024 2:58:49 PM
It looks like the study will be doi (6)
CYDY CytoDyn Inc
09/09/2024 9:47:38 PM
That study is meant to clarify the (24)
CYDY CytoDyn Inc
09/09/2024 5:01:53 PM
A broker I have used in the past sa (18)
CYDY CytoDyn Inc
09/09/2024 11:28:21 AM
Chronic fatigue!! First I've heard (24)
CYDY CytoDyn Inc
09/07/2024 12:28:09 AM
Chan was receiving radiation therap (37)
CYDY CytoDyn Inc
09/05/2024 12:04:03 PM
Most new investors won't touch a pe (17)
CYDY CytoDyn Inc
09/05/2024 11:56:41 AM
How is it that so few investors hav (9)
CYDY CytoDyn Inc
09/05/2024 11:47:24 AM
So, speaking of research, I took a (27)
CYDY CytoDyn Inc
09/04/2024 10:09:34 PM
In such a scenario, does it seem od (16)
CYDY CytoDyn Inc
09/04/2024 2:23:18 PM
Are stubbed toes on Ohm's list? It (5)
CYDY CytoDyn Inc
09/04/2024 2:20:09 PM
Sepsis is an extremely overactive i (11)
CYDY CytoDyn Inc
09/04/2024 2:08:53 PM
One could argue that if I'm I'm buy (19)
CYDY CytoDyn Inc
09/04/2024 2:02:47 PM
Ohm. Any thoughts on the likely mar (18)
CYDY CytoDyn Inc
09/02/2024 10:34:55 AM
Interesting Institutes like Mount S (23)
CYDY CytoDyn Inc
09/01/2024 2:26:15 PM
" Research reveals that persistent (26)
CYDY CytoDyn Inc
08/28/2024 2:26:18 PM
Does any GOOD protein (or non-prote (21)
CYDY CytoDyn Inc
08/28/2024 8:03:02 AM
I am assuming that for acute indica (15)
CYDY CytoDyn Inc
08/28/2024 1:26:23 AM
Hoping for beautiful pink mouse liv (13)
CYDY CytoDyn Inc
08/28/2024 1:17:08 AM
On the leronlimab regulator list - (21)
CYDY CytoDyn Inc
08/26/2024 6:24:17 PM
I'm surprised you don't believe wha (3)
CYDY CytoDyn Inc
08/26/2024 5:30:06 PM
I would need the data before assumi (14)
CYDY CytoDyn Inc
08/26/2024 3:09:41 PM
Although excess mortality could act (10)
CYDY CytoDyn Inc
08/26/2024 3:04:15 PM
How about conjugating LL with a che (8)
CYDY CytoDyn Inc
08/26/2024 2:59:54 PM
Any "big pharma" can mfgr another " (17)
CYDY CytoDyn Inc
08/26/2024 12:49:44 PM
I have believed for years that Long (16)
CYDY CytoDyn Inc
08/26/2024 12:41:33 PM
Dual Targeting: By combining a CCR5 (11)
CYDY CytoDyn Inc
08/26/2024 10:20:38 AM
If so, why do it using bevacizumab (23)
CYDY CytoDyn Inc
08/26/2024 12:27:21 AM
12 yrs knocks off 6 yrs of LL's pat (14)
CYDY CytoDyn Inc
08/26/2024 12:21:22 AM
A new combo is a novel formulation (4)
CYDY CytoDyn Inc
08/26/2024 12:19:06 AM
Not sure if I understand your quest (5)
CYDY CytoDyn Inc
08/26/2024 12:18:58 AM
The question is, can the original o (5)
CYDY CytoDyn Inc
08/25/2024 10:05:29 AM
WE will likely be used as a adjuvan (29)
CYDY CytoDyn Inc
08/24/2024 12:19:25 AM
The scalawag will never learn. I'm (21)
CYDY CytoDyn Inc
08/23/2024 2:38:53 PM
Do you think they would consider th (4)
Go to page:
  • << First
  • < Previous
  • 10
  • 11
  • Next >

Recent Articles

  • Tim Cook's Gift to Trump Reflects Apple's $100 Billion Pledge
  • AT&T Inc. Reveals $177 Million Settlement for Data Breaches
  • Overcoming the Challenges of Connected TV Advertising Today
  • The Impact of AI on Financial Markets: A Cautionary Tale
  • Kevin O'Leary's Innovative Executive Hiring Model Explained
  • New Talks Aim for Lasting Peace as Tensions Escalate
  • Innovative AI Platform from GridStrat Enhances Market Strategies
  • New Chip Export Dynamics Shaping Global Semiconductor Market
  • Investors Urged to Act as Hims & Hers Health Faces Legal Scrutiny
  • Petco Investors Examined for Claims Amid Stock Decline
  • Transforming Work: AI Replaces Soul-Crushing Jobs Amid Growth
  • Investigation Launched on Investor Claims against Centene Corp
  • John Paulson Expands Portfolio with Alphabet and Gold Miner
  • ExpandCommunication Revolutionizes Public Relations with AI
  • Important Investor Update on Sarepta Therapeutics' Safety Claims
  • Rillet Secures $70M Investment to Innovate AI in Accounting
  • Coatue Management's Strategic Bet on AI and Cloud Growth
  • Celebrate Nature With the New Luna Moth Stamp Release
  • Lineage, Inc. Investors: Important Class Action Deadline Ahead
  • Legal Action Update: Investors Target Novo and Others
  • Jim Cramer Encourages Investors to Stay Confident Amid Market Swings
  • Centene Corporation Securities Class Action: Key Details for Investors
  • Explore the Hidden Industries Booming Under the Radar
  • Understanding Relevant Class Actions Against Major Firms
  • Replimune Group, Inc. Investors Should Take Action Now
  • Greenlight Capital's Strategic Moves: Insights into Q2 2025
  • Class Action Alert: Reddit Investors Must Act Before Deadline
  • Understanding the Legal Activity Surrounding Hims Inc. Shares
  • Sarepta Therapeutics Faces Lawsuit: Take Action Before Deadline
  • Alto Neuroscience Shareholder Class Action: Important Updates
  • Datumo's $15.5 Million Fund Boosts AI Evaluation Tools
  • IRS Clarifies No New Stimulus Checks Will Be Issued This Year
  • CTO Realty Growth Investors: Act Now for Class Action Rights
  • Danielle Panabaker's Crossover Experience: Pay Issues Revealed
  • New Forever Stamp Celebrates Legacy of Former President Carter
  • XPPen Marks 20 Years of Innovation and Creativity in Art
  • Investigation Launched for Investors of GSK plc Amid Concerns
  • Unraveling Investor Concerns Involving Confluent, Inc. Stock
  • Investigation into Neogen Corporation Raises Concerns for Investors
  • Class Action Filed Against Alto Neuroscience Over IPO Misrepresentation
  • Class Action Lawsuit Announced Against Hims & Hers Health, Inc.
  • Understanding the Legal Landscape for PetMed Investors
  • Class Action Filed Against Flywire Corporation: A Legal Overview
  • Investigation into Unicycive Therapeutics Raises Consumer Concerns
  • Join the Class Action Against XPLR Infrastructure: Your Rights Matter
  • Dyne Therapeutics Faces Investigations Over Alleged Fraud Claims
  • iRobot Faces Class Action Lawsuit as Investor Confidence Wanes
  • Ricardo Salinas Plans Full Bitcoin Investment Strategy
  • Investigation Announced for Geely Automobile Holdings Investors
  • Capricor Therapeutics Faces Investigation Amid Stock Concerns
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site